[PHARMA] YoY TTM Result on 30-Sep-2011 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
01-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- 6.23%
YoY- -30.42%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 2,063,690 1,861,183 1,697,728 1,529,311 1,326,138 1,305,133 1,270,220 8.42%
PBT 120,733 64,238 115,434 54,117 75,653 78,444 89,675 5.07%
Tax -41,862 -36,212 -32,578 -15,466 -21,273 -20,911 -29,741 5.86%
NP 78,871 28,026 82,856 38,651 54,380 57,533 59,934 4.68%
-
NP to SH 77,960 26,453 81,587 37,959 54,554 56,067 58,311 4.95%
-
Tax Rate 34.67% 56.37% 28.22% 28.58% 28.12% 26.66% 33.17% -
Total Cost 1,984,819 1,833,157 1,614,872 1,490,660 1,271,758 1,247,600 1,210,286 8.58%
-
Net Worth 507,124 473,402 496,469 464,092 424,488 407,858 374,393 5.18%
Dividend
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Div 57,457 37,168 64,713 - 89,852 86,673 38,516 6.89%
Div Payout % 73.70% 140.51% 79.32% - 164.70% 154.59% 66.05% -
Equity
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Net Worth 507,124 473,402 496,469 464,092 424,488 407,858 374,393 5.18%
NOSH 258,737 258,689 117,646 106,933 106,924 107,049 106,969 15.85%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin 3.82% 1.51% 4.88% 2.53% 4.10% 4.41% 4.72% -
ROE 15.37% 5.59% 16.43% 8.18% 12.85% 13.75% 15.57% -
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 797.60 719.47 1,443.07 1,430.15 1,240.26 1,219.19 1,187.46 -6.41%
EPS 30.13 10.23 69.35 35.50 51.02 52.37 54.51 -9.40%
DPS 22.20 14.37 55.00 0.00 84.00 81.00 36.00 -7.73%
NAPS 1.96 1.83 4.22 4.34 3.97 3.81 3.50 -9.20%
Adjusted Per Share Value based on latest NOSH - 106,933
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 143.19 129.14 117.80 106.11 92.01 90.56 88.13 8.42%
EPS 5.41 1.84 5.66 2.63 3.79 3.89 4.05 4.94%
DPS 3.99 2.58 4.49 0.00 6.23 6.01 2.67 6.92%
NAPS 0.3519 0.3285 0.3445 0.322 0.2945 0.283 0.2598 5.18%
Price Multiplier on Financial Quarter End Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 -
Price 4.63 4.82 7.55 5.90 4.98 4.09 3.24 -
P/RPS 0.58 0.67 0.52 0.41 0.40 0.34 0.27 13.58%
P/EPS 15.37 47.14 10.89 16.62 9.76 7.81 5.94 17.16%
EY 6.51 2.12 9.19 6.02 10.25 12.81 16.82 -14.62%
DY 4.79 2.98 7.28 0.00 16.87 19.80 11.11 -13.07%
P/NAPS 2.36 2.63 1.79 1.36 1.25 1.07 0.93 16.78%
Price Multiplier on Announcement Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 24/11/08 -
Price 4.45 4.72 8.25 5.90 4.92 3.93 3.35 -
P/RPS 0.56 0.66 0.57 0.41 0.40 0.32 0.28 12.24%
P/EPS 14.77 46.16 11.90 16.62 9.64 7.50 6.15 15.71%
EY 6.77 2.17 8.41 6.02 10.37 13.33 16.27 -13.59%
DY 4.99 3.04 6.67 0.00 17.07 20.61 10.75 -12.00%
P/NAPS 2.27 2.58 1.95 1.36 1.24 1.03 0.96 15.41%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment